With the high mortality rate, coronary heart disease (CHD) has currently become a major life-
threatening disease. The main pathological change of myocardial infarction (MI) is the …

Acute myocardial infarction is a major problem of world public health and available
treatments have limited efficacy. Cardiac cell therapy is a new therapeutic strategy focused …

Importance of the field: Mesenchymal stem cells (MSCs) have the greatest potential for use
in cell-based therapy of human heart diseases, especially in myocardial infarcts. The …

Ischemic heart damage usually triggers cardiomyopathological remodeling and fibrosis, thus
promoting the development of heart functional failure. Mesenchymal stem cells (MSCs) are a …

Opinion statement Owing to the prevalence of heart disease and the lack of effective long-
term solutions for managing cardiac injury, research has turned to cell therapy as a potential …

Mesenchymal stem cells (MSCs) represent a population of adult stem cells residing in many
tissues, mainly bone marrow, adipose tissue, and umbilical cord. Due to the safety and …

Irreversible myocardium infarction is one of the leading causes of cardiovascular disease
(CVD) related death and its quantum is expected to grow in coming years. Pharmacological …

For decades, mesenchymal stem (MSCs) cells have been used for cardiovascular diseases
as regenerative therapy. This review is an attempt to summarize the types of MSCs involved …

The pandemic of cardiovascular disease is continuously expanding as the result of
changing life styles and diets throughout the Old and New World. Immediate intervention …

Cardiovascular disease (CVD) is the leading cause of death worldwide. According to the
World Health Organization (WHO), an estimate of 17.3 million people died from CVDs in …